Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ryan Callahan

Orthopaedic Surgery Rupert, ID Doctor of Osteopathy

NPI 1962765222 CMS profile 316416

1218 9Th St Ste 10, Rupert, ID 83350

Open in the dashboard

General payments

$11,834

112 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ryan Callahan of Rupert, ID is reported in the CMS Open Payments database as having received $11,834 across 112 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,888 15
2024 General $322 9
2023 General $163 9
2022 General $2,574 11
2021 General $1,677 24
2020 General $266 11
2019 General $3,944 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan Callahan
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Ryan Callahan were reported at $2,888. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Ryan Callahan Orthopaedic Surgery median Middle half National median
2019 $3,944 $644 $140–$2,844 $163
2020 $266 $312 $75–$1,860 $114
2021 $1,677 $520 $117–$2,495 $132
2022 $2,574 $598 $128–$2,731 $149
2023 $163 $461 $128–$2,264 $160
2024 $322 $497 $134–$2,475 $164
2025 $2,888 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Steelhead Surgical Inc $3,549 5 payments
  2. Stryker Corporation $2,707 72 payments
  3. Active Medical, LLC $2,685 6 payments
  4. Arthrex, Inc. $2,314 14 payments
  5. Wright Medical Technology, Inc. $211 3 payments
  6. Zimmer Biomet Holdings, Inc. $135 2 payments
  7. Paragon 28, Inc. $72 2 payments
  8. Boston Scientific Corporation $49 2 payments
  9. Bioventus LLC $36 2 payments
  10. Treace Medical Concepts, Inc. $25 1 payment
  11. Other $49 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $6,216 15 payments
  2. Food and Beverage $2,975 95 payments
  3. Education $2,643 2 payments
Products named General payments · program years 2019–2025
  1. STAR Trauma & Extremeties $604 3 payments
  2. ACCOLADE Hips $414 18 payments
  3. INFINITY $211 3 payments
  4. AXS INFINITY LS $210 7 payments
  5. HOFFMANN $179 5 payments
  6. ACCOLADE Hips $139 7 payments
  7. Comprehensive Primary Stem $107 1 payment
  8. STAR Trauma & Extremeties $86 3 payments
  9. ANCHORAGE $66 3 payments
  10. APEX 3D $59 1 payment
  11. Other $586 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

124

Median for Orthopedic Surgery: 203

Drug cost

$1,494

Median for Orthopedic Surgery: $1,433

Branded share of claims

58.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Hyclate Generic 19 $575
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 42 $524
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 30 $233
Oxycodone Hcl Generic 17 $105
Tramadol Hcl Generic 16 $56

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 78 billing codes

Paid by Medicare

$68,627

Of which drugs: $54

Medicare patients

183

Average age 73

Services billed

1,144

119 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 70%
Depression 28%
Diabetes 22%
Chronic kidney disease 22%
Ischemic heart disease 20%
Osteoporosis 17%
Heart failure 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 18 264 $25
Injection, bupivicaine, not otherwise specified, 0.5 mg J0665 Office 17 337 $4

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

112 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record